Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$34,806,844
+$11,568,908 QoQ
Shares Held
138,320
+29.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#445
of 4,153 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MIZUHO SECURITIES USA LLC holds $231,832,620 across 9 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
61,931 | $74,281,905 | |
| 2 | JNJ |
Johnson & Johnson
|
188,458 | $47,862,678 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
138,320 | $34,806,844 | |
| 4 | MRK |
Merck & Co., Inc.
|
193,359 | $24,846,631 | |
| 5 | AMGN |
Amgen Inc
|
42,253 | $15,300,656 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
97,201 | $12,280,374 | |
| 7 | PFE |
Pfizer Inc
|
446,202 | $10,744,544 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
159,871 | $9,211,767 |
All Filings in ABBV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,806,844 | 138,320 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $23,237,936 | 106,846 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $29,404,149 | 128,689 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $29,790,862 | 128,664 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $22,659,561 | 122,075 | Shares | Defined | 2025-08-01 | |
| No filing history on record for this holder in this stock. | ||||||